• Journal of Sasang Constitutional Medicine
• /
• v.21 no.3
• /
• pp.209-215
• /
• 2009

1. Objects: This case study reports a liver injury in treatment of constipation with Yeoldahanso-tang plus Rheum rhabarbarum. 2. Methods: The patient's subjective symptoms and the laboratory data including aspartate transaminase(AST), alanine transaminase(ALT), alkaline phosphatase(ALP), and gamma($\gamma$)-glutamyl transpeptidase(GGT) were observed before and after liver injury. We used the Roussel Uclaf Causality Assessment Method(RUCAM) scale in order to find out whether if Yeoldahanso-tang plus Rheum rhabarbarum was related with the liver injury. 3. Results: The patient's AST and ALT were elevated more than twice after a 3week administration period of herbal medicine. After discontinuation of the herbal medicine and administration of hepatic protective medication, AST and ALT decreased. The patient's general condition improved during hospitalization. The RUCAM score was estimated at 8. 4. Conclusions: This case is presented to bring more attention to the toxicity of herbal medicine.

• The Korean Journal of Mycology
• /
• v.49 no.4
• /
• pp.555-560
• /
• 2021

During disease surveys conducted from 2019 to 2021 in Korea, leaf spot symptoms in rhubarb (Rheum rhabarbarum) plants were frequently observed in plants growing in fields located in Cheolwon, Taebaek, and Inje in Gangwon Province. The incidence of diseased leaves of the plants in the fields ranged from 2% to 80%. Nine single-spore isolates of Phoma sp. were obtained from lesions of the diseased leaves; all of them were identified as Didymella rhei based on their cultural, morphological, and molecular characteristics. Three isolates of D. rhei were tested for pathogenicity on rhubarb leaves using artificial inoculation. All the tested isolates caused leaf spot symptoms in the inoculated plants; the symptoms were similar to those observed in plants from the fields investigated. This is the first report of D. rhei causing leaf spot in rhubarb in Korea.

• 한국약용작물학회:학술대회논문집
• /
• 2011.09a
• /
• pp.160-161
• /
• 2011

• Journal of Periodontal and Implant Science
• /
• v.52 no.5
• /
• pp.383-393
• /
• 2022

Purpose: Aloe-emodin (AE), a natural anthraquinone abundant in aloe plants and rhubarb (Rheum rhabarbarum), has long been used to treat chronic inflammatory diseases. However, AE's underlying mechanisms in periodontal inflammation have not been fully elucidated. Acidic mammalian chitinase (AMCase) is a potential biomarker involved in bone remodeling. This study aimed to evaluate AE's effect on periodontitis in rats and investigate AMCase expression. Methods: Eighteen Sprague-Dawley rats were separated into the following groups: healthy (group 1), disease (group 2), vehicle (group 3), AE high-dose (group 4), and AE low-dose (group 5). Porphyromonas gingivalis ligatures were placed in rats (groups 2-5) for 7 days. Groups 4 and 5 were then treated with AE for an additional 14 days. Saliva was collected from all groups, and probing pocket depth was measured in succession. Periodontal pocket tissues were subjected to histomorphometric analysis after the rats were sacrificed. Bone marrow-derived macrophages and murine macrophages were stimulated with receptor activator of nuclear factor-κB ligand (RANKL) and treated with different concentrations of AE. AMCase expression was detected from the analysis of saliva, periodontal pocket tissues, and differentiated osteoclasts. Results: Among rats with P. gingivalis-induced periodontitis, the alveolar bone resorption levels and periodontal pocket depth were significantly reduced after treatment with AE. AMCase protein expression was significantly higher in the disease group than in the healthy control (P<0.05). However, AE inhibited periodontal inflammation by downregulating AMCase expression in saliva and periodontal pocket tissue. AE significantly reduced RANKL-stimulated osteoclastogenesis by modulating AMCase (P<0.05). Conclusions: AE decreases alveolar bone loss and periodontal inflammation, suggesting that this natural anthraquinone has potential value as a novel therapeutic agent against periodontal disease.